Should (Prophylactic) Medications Be Used for the Management of Death Rattle?

被引:5
|
作者
van Esch, Harriette Johanna [1 ,2 ,6 ,7 ]
Campbell, Margret L. [3 ]
Mori, Masanori [4 ]
Yamaguchi, Takayashi [5 ]
机构
[1] Erasmus MC, Dept Med Oncol, Canc Inst, Rotterdam, Netherlands
[2] Erasmus MC, Dept Publ Hlth, Canc Inst, Rotterdam, Netherlands
[3] Wayne State Univ, Coll Nursing, Detroit, MI USA
[4] Seirei Mikatahara Gen Hosp, Dept Palliat & Support Care, Hamamatsu, Japan
[5] Kobe Univ, Grad Sch Med, Dept Palliat Med, Kobe, Japan
[6] Erasmus MC, Dept Med Oncol, Canc Inst, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands
[7] Erasmus MC, Dept Publ Hlth, Canc Inst, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands
关键词
death rattle; randomised controlled trial; opinion; end-of -life care; RESPIRATORY-DISTRESS; SOUND; LIFE;
D O I
10.1016/j.jpainsymman.2023.06.017
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Death rattle is a common symptom in the dying phase and has impact on relatives and health care providers. One controversial topic regarding the management of death rattle in the dying phase is whether the symptom should be treated. In this "Controversies in Palliative Care" article, three expert clinicians independently answer this question. Specifically, each group provides a synopsis of the key studies that inform their thought processes, share practical advice on their clinical approach, and highlight the opportunities for future research. The three experts have different opinions on the assessment of death rattle. This seems to depend on the unknown burden of death rattle on the patient. Explanation of the symptom and reassurance could be sufficient. But considering the known burden on some of the relatives, there might be good reasons to use medication to relieve this symptom. Whether this treatment should be performed preventively or only when death rattle develops remains an matter of debate. Further scientific, clinical, and societal debate on the concept of a "good death" for relatives, the meaning of the symptom death rattle, and the impact of medication is needed. J Pain Symptom Manage 2023;66:e513-e517. (c) 2023 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:E513 / E517
页数:5
相关论文
共 50 条
  • [41] Empfehlung bei RasselatmungRecommendations for death rattle
    T. Pastrana
    H. Reineke-Bracke
    F. Elsner
    Der Schmerz, 2012, 26 : 600 - 608
  • [42] Should prophylactic surgery be used in women with a high risk of breast cancer? Contra
    Janin, N
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (13) : 2153 - 2158
  • [43] Should prophylactic surgery be used in women with a high risk of breast cancer? Pro
    Klijn, JGM
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (13) : 2149 - 2153
  • [44] Reducing death rattle at the end of life
    Potter, Jen
    Korownyk, Christina S.
    CANADIAN FAMILY PHYSICIAN, 2023, 69 (07) : 477 - 477
  • [45] Scopolamine reduces prefinal Death Rattle
    Krome, Susanne
    PNEUMOLOGIE, 2022, 76 (05): : 305 - 306
  • [46] Glycopyrronium Bromide in terminal Death Rattle
    Baierl, Bettina
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2015, 56 : 741 - 741
  • [47] Understanding relatives’ experience of death rattle
    Harriëtte J. van Esch
    Martine E. Lokker
    Judith Rietjens
    Lia van Zuylen
    Carin C. D. van der Rijt
    Agnes van der Heide
    BMC Psychology, 8
  • [48] Death rattle: Prevalence, prevention and treatment
    Wildiers, H
    Menten, J
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2002, 23 (04) : 310 - 317
  • [49] Response to "Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later" Response
    Mercadante, Sebastiano
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2019, 57 (03) : E13 - E14
  • [50] Understanding relatives' experience of death rattle
    van Esch, Harriette J.
    Lokker, Martine E.
    Rietjens, Judith
    van Zuylen, Lia
    van der Rijt, Carin C. D.
    van der Heide, Agnes
    BMC PSYCHOLOGY, 2020, 8 (01)